Cancer: Curenetics.Io Innovates Tech-Driven Methods To Help Meet NHS Cancer Survival Targets

Curenetics.io has been developing an AI platform that has had encouraging results that will speed up early diagnosis. This is driven through our AI-based E11even cancer blood-based diagnostic test. This could be deployed in primary care and help triage the cancer diagnostic pathway for 11 common, killer cancers. We also have our medical software, CIT-AI, which is able to predict a patient’s response to cancer immunotherapy treatment. Immunotherapy has revolutionised the treatment of many cancers but they could be very expensive